Premenstrual Syndrome Treatment Market Size, Share, Trends, Growth and Forecast 2032

Premenstrual Syndrome Treatment Market

Premenstrual Syndrome Treatment Market By Treatment Type (Pharmaceutical Medications, Complementary & Alternative Therapies, Lifestyle Modifications, and Over-the-Counter Medications), By Distribution Channel (Direct-To-Consumer, Pharmacies, and Hospitals & Clinics), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 221 Report Code: ZMR-9214 Published Date: Jan-2025 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2 Billion USD 3 Billion 4% 2023

Premenstrual Syndrome Treatment Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Premenstrual Syndrome Treatment Market, (2024 - 2032) (USD Billion)
    • 2.2 Global Premenstrual Syndrome Treatment Market : snapshot
  • Chapter 3. Global Premenstrual Syndrome Treatment Market - Industry Analysis
    • 3.1 Premenstrual Syndrome Treatment Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Escalating incidences of premenstrual syndrome across the globe to embellish the growth of the market globally
    • 3.3 Market Restraints
      • 3.3.1. Lesser knowhow among the female population about premenstrual syndrome to constrict the global industry surge
    • 3.4 Market Opportunities
      • 3.4.1. Surging patient inclination towards non-pharmacological therapies to craft panoramas of opportunities for the global market
    • 3.5 Market Challenges
      • 3.5.1. Rising healthcare costs & inadequate compensation policies can challenge the global industry progress
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Treatment Type
      • 3.7.2 Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Premenstrual Syndrome Treatment Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Premenstrual Syndrome Treatment Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Premenstrual Syndrome Treatment Market - Treatment Type Analysis
    • 5.1 Global Premenstrual Syndrome Treatment Market overview: By Treatment Type
      • 5.1.1 Global Premenstrual Syndrome Treatment Market share, By Treatment Type, 2023 and 2032
    • 5.2 Pharmaceutical Medications
      • 5.2.1 Global Premenstrual Syndrome Treatment Market by Pharmaceutical Medications, 2024 - 2032 (USD Billion)
    • 5.3 Complementary & Alternative Therapies
      • 5.3.1 Global Premenstrual Syndrome Treatment Market by Complementary & Alternative Therapies, 2024 - 2032 (USD Billion)
    • 5.4 Lifestyle Modifications
      • 5.4.1 Global Premenstrual Syndrome Treatment Market by Lifestyle Modifications, 2024 - 2032 (USD Billion)
    • 5.5 Over-the-Counter Medications
      • 5.5.1 Global Premenstrual Syndrome Treatment Market by Over-the-Counter Medications, 2024 - 2032 (USD Billion)
  • Chapter 6. Global Premenstrual Syndrome Treatment Market - Distribution Channel Analysis
    • 6.1 Global Premenstrual Syndrome Treatment Market overview: By Distribution Channel
      • 6.1.1 Global Premenstrual Syndrome Treatment Market share, By Distribution Channel, 2023 and 2032
    • 6.2 Direct-To-Consumer
      • 6.2.1 Global Premenstrual Syndrome Treatment Market by Direct-To-Consumer, 2024 - 2032 (USD Billion)
    • 6.3 Pharmacies
      • 6.3.1 Global Premenstrual Syndrome Treatment Market by Pharmacies, 2024 - 2032 (USD Billion)
    • 6.4 Hospitals & Clinics
      • 6.4.1 Global Premenstrual Syndrome Treatment Market by Hospitals & Clinics, 2024 - 2032 (USD Billion)
  • Chapter 7. Premenstrual Syndrome Treatment Market - Regional Analysis
    • 7.1 Global Premenstrual Syndrome Treatment Market Regional Overview
    • 7.2 Global Premenstrual Syndrome Treatment Market Share, by Region, 2023 & 2032 (USD Billion)
    • 7.3. North America
      • 7.3.1 North America Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
        • 7.3.1.1 North America Premenstrual Syndrome Treatment Market, by Country, 2024 - 2032 (USD Billion)
    • 7.4 North America Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032
      • 7.4.1 North America Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032 (USD Billion)
    • 7.5 North America Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032
      • 7.5.1 North America Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032 (USD Billion)
    • 7.4. Europe
      • 7.4.2 Europe Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
        • 7.4.2.1 Europe Premenstrual Syndrome Treatment Market, by Country, 2024 - 2032 (USD Billion)
    • 7.4 Europe Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032
      • 7.4.1 Europe Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032 (USD Billion)
    • 7.5 Europe Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032
      • 7.5.1 Europe Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032 (USD Billion)
    • 7.5. Asia Pacific
      • 7.5.3 Asia Pacific Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
        • 7.5.3.1 Asia Pacific Premenstrual Syndrome Treatment Market, by Country, 2024 - 2032 (USD Billion)
    • 7.4 Asia Pacific Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032
      • 7.4.1 Asia Pacific Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032 (USD Billion)
    • 7.5 Asia Pacific Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032
      • 7.5.1 Asia Pacific Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032 (USD Billion)
    • 7.6. Latin America
      • 7.6.4 Latin America Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
        • 7.6.4.1 Latin America Premenstrual Syndrome Treatment Market, by Country, 2024 - 2032 (USD Billion)
    • 7.4 Latin America Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032
      • 7.4.1 Latin America Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032 (USD Billion)
    • 7.5 Latin America Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032
      • 7.5.1 Latin America Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032 (USD Billion)
    • 7.7. The Middle-East and Africa
      • 7.7.5 The Middle-East and Africa Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
        • 7.7.5.1 The Middle-East and Africa Premenstrual Syndrome Treatment Market, by Country, 2024 - 2032 (USD Billion)
    • 7.4 The Middle-East and Africa Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032
      • 7.4.1 The Middle-East and Africa Premenstrual Syndrome Treatment Market, by Treatment Type, 2024 - 2032 (USD Billion)
    • 7.5 The Middle-East and Africa Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032
      • 7.5.1 The Middle-East and Africa Premenstrual Syndrome Treatment Market, by Distribution Channel, 2024 - 2032 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Teva Pharmaceutical Industries Ltd.
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 Pfizer Inc.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 MetP Pharma AG
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 GlaxoSmithKline
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Eli Lilly and Company
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Novartis International AG
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Asarina Pharma AB
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Merck
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Bayer AG
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Mylan N.V.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
    • 8.11 Pherin Pharmaceuticals
      • 8.11.1 Overview
      • 8.11.2 Financials
      • 8.11.3 Product Portfolio
      • 8.11.4 Business Strategy
      • 8.11.5 Recent Developments
    • 8.12 Umecrine Mood AB
      • 8.12.1 Overview
      • 8.12.2 Financials
      • 8.12.3 Product Portfolio
      • 8.12.4 Business Strategy
      • 8.12.5 Recent Developments
    • 8.13 Chattem Inc.
      • 8.13.1 Overview
      • 8.13.2 Financials
      • 8.13.3 Product Portfolio
      • 8.13.4 Business Strategy
      • 8.13.5 Recent Developments
    • 8.14 H. Lundbeck A/S
      • 8.14.1 Overview
      • 8.14.2 Financials
      • 8.14.3 Product Portfolio
      • 8.14.4 Business Strategy
      • 8.14.5 Recent Developments
    • 8.15 and others.
      • 8.15.1 Overview
      • 8.15.2 Financials
      • 8.15.3 Product Portfolio
      • 8.15.4 Business Strategy
      • 8.15.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Premenstrual Syndrome Treatment Market attractiveness, By Treatment Type
  • 6. Global Premenstrual Syndrome Treatment Market attractiveness, By Distribution Channel
  • 7. Global Premenstrual Syndrome Treatment Market share by Treatment Type, 2024 and 2032 (USD Billion)
  • 8. Global Premenstrual Syndrome Treatment Market by Pharmaceutical Medications, 2024 - 2032 (USD Billion)
  • 9. Global Premenstrual Syndrome Treatment Market by Complementary & Alternative Therapies, 2024 - 2032 (USD Billion)
  • 10. Global Premenstrual Syndrome Treatment Market by Lifestyle Modifications, 2024 - 2032 (USD Billion)
  • 11. Global Premenstrual Syndrome Treatment Market by Over-the-Counter Medications, 2024 - 2032 (USD Billion)
  • 12. Global Premenstrual Syndrome Treatment Market share by Distribution Channel, 2024 and 2032 (USD Billion)
  • 13. Global Premenstrual Syndrome Treatment Market by Direct-To-Consumer, 2024 - 2032 (USD Billion)
  • 14. Global Premenstrual Syndrome Treatment Market by Pharmacies, 2024 - 2032 (USD Billion)
  • 15. Global Premenstrual Syndrome Treatment Market by Hospitals & Clinics, 2024 - 2032 (USD Billion)
  • 16. Global Premenstrual Syndrome Treatment Market share, by Region, 2024 and 2032
  • 17. North America Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
  • 18. Europe Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
  • 19. Asia Pacific Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
  • 20. Latin America Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)
  • 21. The Middle-East and Africa Premenstrual Syndrome Treatment Market, 2024 - 2032 (USD Billion)

Table Of Tables

  • 1. Global Premenstrual Syndrome Treatment Market: Snapshot
  • 2. Drivers of the Premenstrual Syndrome Treatment Market: impact analysis
  • 3. North America Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 4. North America Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 5. U.S. Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 6. U.S. Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 7. Canada Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 8. Canada Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 9. Europe Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 10. Europe Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 11. Germany Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 12. Germany Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 13. France Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 14. France Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 15. U.K. Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 16. U.K. Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 17. Italy Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 18. Italy Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 19. Spain Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 20. Spain Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 21. Rest of Europe Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 22. Rest of Europe Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 23. Asia Pacific Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 24. Asia Pacific Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 25. China Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 26. China Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 27. Japan Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 28. Japan Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 29. India Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 30. India Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 31. South Korea Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 32. South Korea Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 33. South-East Asia Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 34. South-East Asia Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 35. Rest of Asia Pacific Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 36. Rest of Asia Pacific Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 37. Latin America Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 38. Latin America Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 39. Brazil Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 40. Brazil Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 41. Mexico Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 42. Mexico Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 43. Rest of Latin America Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 44. Rest of Latin America Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 45. The Middle-East and Africa Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 46. The Middle-East and Africa Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 47. GCC Countries Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 48. GCC Countries Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 49. South Africa Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 50. South Africa Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)
  • 51. Rest of Middle-East Africa Premenstrual Syndrome Treatment Market revenue, By Treatment Type, 2024 - 2032 (USD Billion)
  • 52. Rest of Middle-East Africa Premenstrual Syndrome Treatment Market revenue, By Distribution Channel, 2024 - 2032 (USD Billion)

Methodology

FrequentlyAsked Questions

Premenstrual syndrome is a common condition causing physical, behavioral, and emotional changes occurring in the luteal phase of the menstrual cycle. Symptoms can differ from woman to woman and treatment can vary based upon the symptoms.

The global premenstrual syndrome treatment market growth over the forecast period can be owing to a huge focus on improving women’s health and breakthroughs in medical treatments such as hormone therapies, analgesics, and anti-depressants.

According to a study, the global premenstrual syndrome treatment industry size was $2 billion in 2023 and is projected to reach $3 billion by the end of 2032.

The global premenstrual syndrome treatment market is anticipated to record a CAGR of nearly 4% from 2024 to 2032.

The Asia-Pacific premenstrual syndrome treatment industry is set to register the fastest CAGR over the forecasting timeframe owing to the surging women population in countries such as India, Bangladesh, Pakistan, and China.  Demand for advanced healthcare services and an increase in the per capita income in Asia will propel the expansion of the industry in APAC.                             

The global premenstrual syndrome treatment market is led by players such as Teva Pharmaceutical Industries Ltd., Pfizer Inc., MetP Pharma AG, GlaxoSmithKline, Eli Lilly and Company, Novartis International AG, Asarina Pharma AB, Merck, Bayer AG, Mylan N.V., Pherin Pharmaceuticals, Umecrine Mood AB, Chattem Inc., and H. Lundbeck A/S. 

The global premenstrual syndrome treatment market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, cash-benefit analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, factor analysis, and value chain analysis. It provides an apt scenario about demand and factor conditions in the country impacting the profitability of the firms in the domestic and international markets.

Choose License Type

  • zion payment modes

List of Contents

Premenstrual Syndrome TreatmentIndustry Prospective:OverviewKey InsightsGrowth FactorsRestraintsOpportunitiesChallengesReport ScopeSegmentationRegional InsightsCompetitive Space

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed